
|Articles|June 19, 2008
Allergan's Trivaris approved to treat retinal diseases
Allergan, Trivaris, retinal diseases, vision loss, ocular
Advertisement
Trivaris (triamcinolone acetonide injectable suspension) 80 mg/mL is a new anti-inflammatory drug from
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Pharmacists Essential for Managing Patient Safety in Self-Medication
3
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
4
COVID-19 Booster Comparison Shows Higher Antibody Levels With mRNA Vaccine
5






























